Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Sprog
Alle Felter
Titel
Forfatter
Fag
Klassifikationsnummer
ISBN/ISSN
Tag
Find
Udvidet
Ranibizumab versus Bevacizuma...
Citér dette
Stav dette
Email dette
Udskriv
Eksportér post
Eksportér til RefWorks
Eksportér til EndNoteWeb
Eksportér til EndNote
Permanent link
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Bibliografiske detaljer
Main Authors:
Chakravarthy, U
,
Harding, S
,
Rogers, C
,
Downes, S
,
Lotery, A
,
Wordsworth, S
,
Reeves, B
Format:
Journal article
Udgivet:
2012
Beholdninger
Beskrivelse
Lignende værker
Medarbejdervisning
Lignende værker
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
af: Chakravarthy, U, et al.
Udgivet: (2012)
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial
af: Chakravarthy, U, et al.
Udgivet: (2012)
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial.
af: Dakin, H, et al.
Udgivet: (2014)
Bevacizumab versus ranibizumab for neovascular age-related macular degeneration:a Meta-analysis
af: Wen-Jie Wang, et al.
Udgivet: (2015-02-01)
Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
af: Zhe-Li Liu, et al.
Udgivet: (2013-04-01)